Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

View ORCID ProfileNicholas G. Davies, Sam Abbott, Rosanna C. Barnard, Christopher I. Jarvis, Adam J. Kucharski, View ORCID ProfileJames D. Munday, Carl A. B. Pearson, View ORCID ProfileTimothy W. Russell, Damien C. Tully, Alex D. Washburne, Tom Wenseleers, Amy Gimma, William Waites, Kerry L. M. Wong, View ORCID ProfileKevin van Zandvoort, Justin D. Silverman, CMMID COVID-19 Working Group, The COVID-19 Genomics UK (COG-UK) Consortium, Karla Diaz-Ordaz, Ruth Keogh, View ORCID ProfileRosalind M. Eggo, View ORCID ProfileSebastian Funk, View ORCID ProfileMark Jit, Katherine E. Atkins, W. John Edmunds
doi: https://doi.org/10.1101/2020.12.24.20248822
Nicholas G. Davies
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicholas G. Davies
  • For correspondence: nicholas.davies@lshtm.ac.uk
Sam Abbott
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosanna C. Barnard
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher I. Jarvis
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam J. Kucharski
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James D. Munday
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James D. Munday
Carl A. B. Pearson
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy W. Russell
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Timothy W. Russell
Damien C. Tully
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex D. Washburne
2Selva Analytics LLC, Bozeman, MT, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom Wenseleers
3Lab of Socioecology and Social Evolution, KU Leuven, Leuven, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy Gimma
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Waites
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerry L. M. Wong
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin van Zandvoort
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kevin van Zandvoort
Justin D. Silverman
4College of Information Science and Technology, Pennsylvania State University, University Park, PA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Karla Diaz-Ordaz
6Centre for Statistical Methodology and Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth Keogh
6Centre for Statistical Methodology and Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosalind M. Eggo
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rosalind M. Eggo
Sebastian Funk
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sebastian Funk
Mark Jit
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark Jit
Katherine E. Atkins
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
7Centre for Global Health, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. John Edmunds
1Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

A novel SARS-CoV-2 variant, VOC 202012/01 (lineage B.1.1.7), emerged in southeast England in November 2020 and is rapidly spreading towards fixation. Using a variety of statistical and dynamic modelling approaches, we estimate that this variant has a 43–90% (range of 95% credible intervals 38–130%) higher reproduction number than preexisting variants. A fitted two-strain dynamic transmission model shows that VOC 202012/01 will lead to large resurgences of COVID-19 cases. Without stringent control measures, including limited closure of educational institutions and a greatly accelerated vaccine roll-out, COVID-19 hospitalisations and deaths across England in 2021 will exceed those in 2020. Concerningly, VOC 202012/01 has spread globally and exhibits a similar transmission increase (59–74%) in Denmark, Switzerland, and the United States.

Competing Interest Statement

ADW owns Selva Analytics LLC. All other authors declare no competing interests.

Funding Statement

NGD: UK Research and Innovation (UKRI) Research England; National Institute for Health Research (NIHR) Health Protection Research Unit in Immunisation (NIHR200929); UK Medical Research Council (MRC) (MC_PC_19065). SA: Wellcome Trust (WT) (210758/Z/18/Z). RCB: European Commission (EC) (EpiPose 101003688). CIJ: Global Challenges Research Fund managed through Research Councils UK and the Economic and Social Research Council (RECAP ES/P010873/1). AJK: WT (206250/Z/17/Z); NIHR (NIHR200908). JDM: WT (210758/Z/18/Z). CABP: Bill & Melinda Gates Foundation (BMGF) (OPP1184344); UK Foreign, Commonwealth and Development Office (FCDO) / WT (221303/Z/20/Z). TWR: WT (206250/Z/17/Z). AG: EC (EpiPose 101003688). WW: NIHR (COV0335), MRC (MR/V027956/1). KvZ: FCDO / WT (221303/Z/20/Z); Elrha's Research for Health in Humanitarian Crises Programme funded by FCDO, WT, and NIHR. KDO: Royal Society-WT Sir Henry Dale Fellowship 218554/Z/19/Z. RHK: UKRI Future Leaders Fellowship (MR/S017968/1). RME: Health Data Research UK (MR/S003975/1); MRC (MC_PC 19065); NIHR (NIHR200908). SF: WT (210758/Z/18/Z); NIHR (NIHR200908). MJ: BMGF (INV-003174, INV-016832); NIHR (16/137/109, NIHR200929, NIHR200908); EC (EpiPose 101003688). KEA: European Research Council (757688). WJE: EC (EpiPose 101003688); NIHR (NIHR200908). COG-UK is supported by funding from the MRC, part of UKRI; the NIHR; and Genome Research Limited, operating as the Wellcome Sanger Institute. The CMMID COVID-19 Working Group is (randomized order): Sophie R Meakin, James D Munday, Amy Gimma, Rosanna C Barnard, Timothy W Russell, Billy J Quilty, Yang Liu, Stefan Flasche, Jiayao Lei, Adam J Kucharski, William Waites, Sebastian Funk, Fiona Yueqian Sun, Fabienne Krauer, Rachel Lowe, Nikos I Bosse, Damien C Tully, Emily S Nightingale, Katharine Sherratt, Rosalind M Eggo, Kaja Abbas, Kathleen O'Reilly, Hamish P Gibbs, C Julian Villabona-Arenas, Naomi R Waterlow, W John Edmunds, Graham Medley, Oliver Brady, Jack Williams, Alicia Rosello, Christopher I Jarvis, Petra Klepac, Mihaly Koltai, Nicholas G. Davies, Frank G Sandmann, Anna M Foss, Sam Abbott, Yalda Jafari, Kiesha Prem, Yung-Wai Desmond Chan, Katherine E. Atkins, Carl A B Pearson, Joel Hellewell, Kevin van Zandvoort, Simon R Procter, Thibaut Jombart, Gwenan M Knight, Akira Endo, Matthew Quaife, Mark Jit, Alicia Showering, Samuel Clifford. Funding for the CMMID COVID-19 Working Group is as follows. SRM: Wellcome Trust (grant: 210758/Z/18/Z). JDM: Wellcome Trust (grant: 210758/Z/18/Z). AG: European Commission (EpiPose 101003688). RCB: European Commission (EpiPose 101003688). TWR: Wellcome Trust (grant: 206250/Z/17/Z). BJQ: This research was partly funded by the National Institute for Health Research (NIHR) (16/137/109 & 16/136/46) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care. BJQ is supported in part by a grant from the Bill and Melinda Gates Foundation (OPP1139859). YL: Bill & Melinda Gates Foundation (INV-003174), NIHR (16/137/109), European Commission (101003688). SFlasche: Wellcome Trust (grant: 208812/Z/17/Z). JYL: Bill & Melinda Gates Foundation (INV-003174). AJK: Wellcome Trust (grant: 206250/Z/17/Z), NIHR (NIHR200908). WW: UK Medical Research Council (MRC) (grant MR/V027956/1). S. Funk: Wellcome Trust (grant: 210758/Z/18/Z), NIHR (NIHR200908). FYS: NIHR EPIC grant (16/137/109). FK: Innovation Fund of the Joint Federal Committee (Grant number 01VSF18015), Wellcome Trust (UNS110424). RL: Royal Society Dorothy Hodgkin Fellowship. NIB: Health Protection Research Unit (grant code NIHR200908). DCT: No funding declared. ESN: Bill & Melinda Gates Foundation (OPP1183986). KS: Wellcome Trust (grant: 210758/Z/18/Z). RME: HDR UK (grant: MR/S003975/1), MRC (grant: MC_PC 19065), NIHR (grant: NIHR200908). KA: Bill & Melinda Gates Foundation (OPP1157270, INV-016832). KO'R: Bill and Melinda Gates Foundation (OPP1191821). HPG: This research was produced by CSIGN which is part of the EDCTP2 programme supported by the European Union (grant number RIA2020EF-2983-CSIGN). The views and opinions of authors expressed herein do not necessarily state or reflect those of EDCTP. This research is funded by the Department of Health and Social Care using UK Aid funding and is managed by the NIHR. The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health and Social Care (PR-OD-1017-20001). CJVA: European Research Council Starting Grant (Action number 757688). NRW: Medical Research Council (grant number MR/N013638/1). WJE: European Commission (EpiPose 101003688), NIHR (NIHR200908). GFM: NTD Modelling Consortium by the Bill and Melinda Gates Foundation (OPP1184344). OJB: Wellcome Trust (grant: 206471/Z/17/Z). JW: NIHR Health Protection Research Unit and NIHR HTA. AR: NIHR (grant: PR-OD-1017-20002). CIJ: Global Challenges Research Fund (GCRF) project 'RECAP' managed through RCUK and ESRC (ES/P010873/1). PK: This research was partly funded by the Royal Society under award RP\EA\180004, European Commission (101003688), Bill & Melinda Gates Foundation (INV-003174). MK: Foreign, Commonwealth and Development Office / Wellcome Trust. NGD: UKRI Research England; NIHR Health Protection Research Unit in Immunisation (NIHR200929); UK MRC (MC_PC_19065). FGS: NIHR Health Protection Research Unit in Modelling & Health Economics, and in Immunisation. AMF: No funding declared. SA: Wellcome Trust (grant: 210758/Z/18/Z). YJ: LSHTM, DHSC/UKRI COVID-19 Rapid Response Initiative. KP: Bill & Melinda Gates Foundation (INV-003174), European Commission (101003688). YWDC: No funding declared. KEA: European Research Council Starting Grant (Action number 757688). CABP: CABP is supported by the Bill & Melinda Gates Foundation (OPP1184344) and the UK Foreign, Commonwealth and Development Office (FCDO)/Wellcome Trust Epidemic Preparedness Coronavirus research programme (ref. 221303/Z/20/Z). JH: Wellcome Trust (grant: 210758/Z/18/Z). KvZ: KvZ is supported by the UK Foreign, Commonwealth and Development Office (FCDO)/Wellcome Trust Epidemic Preparedness Coronavirus research programme (ref. 221303/Z/20/Z), and Elrha's Research for Health in Humanitarian Crises (R2HC) Programme, which aims to improve health outcomes by strengthening the evidence base for public health interventions in humanitarian crises. The R2HC programme is funded by the UK Government (FCDO), the Wellcome Trust, and the UK National Institute for Health Research (NIHR). SRP: Bill and Melinda Gates Foundation (INV-016832). TJ: RCUK/ESRC (grant: ES/P010873/1); UK PH RST; NIHR HPRU Modelling & Health Economics (NIHR200908). GMK: UK Medical Research Council (grant: MR/P014658/1). AE: The Nakajima Foundation. MQ: European Research Council Starting Grant (Action Number #757699); Bill and Melinda Gates Foundation (INV-001754). MJ: Bill & Melinda Gates Foundation (INV-003174, INV-016832), NIHR (16/137/109, NIHR200929, NIHR200908), European Commission (EpiPose 101003688). AS: No funding declared. SC: Wellcome Trust (grant: 208812/Z/17/Z).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No ethical approval is required for this modelling study, which uses non-identifiable epidemiological data.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵5 https://www.cogconsortium.uk

  • ↵‡ Members and affiliations are listed in Supplementary Text 1 & 2.

  • Minor revisions.

Data Availability

All analysis code and data have been made publicly available.

https://www.github.com/nicholasdavies/newcovid

https://zenodo.org/record/4562961

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted March 05, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies, Sam Abbott, Rosanna C. Barnard, Christopher I. Jarvis, Adam J. Kucharski, James D. Munday, Carl A. B. Pearson, Timothy W. Russell, Damien C. Tully, Alex D. Washburne, Tom Wenseleers, Amy Gimma, William Waites, Kerry L. M. Wong, Kevin van Zandvoort, Justin D. Silverman, CMMID COVID-19 Working Group, The COVID-19 Genomics UK (COG-UK) Consortium, Karla Diaz-Ordaz, Ruth Keogh, Rosalind M. Eggo, Sebastian Funk, Mark Jit, Katherine E. Atkins, W. John Edmunds
medRxiv 2020.12.24.20248822; doi: https://doi.org/10.1101/2020.12.24.20248822
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies, Sam Abbott, Rosanna C. Barnard, Christopher I. Jarvis, Adam J. Kucharski, James D. Munday, Carl A. B. Pearson, Timothy W. Russell, Damien C. Tully, Alex D. Washburne, Tom Wenseleers, Amy Gimma, William Waites, Kerry L. M. Wong, Kevin van Zandvoort, Justin D. Silverman, CMMID COVID-19 Working Group, The COVID-19 Genomics UK (COG-UK) Consortium, Karla Diaz-Ordaz, Ruth Keogh, Rosalind M. Eggo, Sebastian Funk, Mark Jit, Katherine E. Atkins, W. John Edmunds
medRxiv 2020.12.24.20248822; doi: https://doi.org/10.1101/2020.12.24.20248822

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (505)
  • Anesthesia (110)
  • Cardiovascular Medicine (1242)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (532)
  • Epidemiology (10027)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2461)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1645)
  • Health Policy (753)
  • Health Systems and Quality Improvement (636)
  • Hematology (250)
  • HIV/AIDS (535)
  • Infectious Diseases (except HIV/AIDS) (11870)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2288)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1248)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (325)
  • Pediatrics (732)
  • Pharmacology and Therapeutics (314)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4840)
  • Radiology and Imaging (838)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (651)
  • Rheumatology (286)
  • Sexual and Reproductive Health (240)
  • Sports Medicine (227)
  • Surgery (268)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)